LOGUFEN
PHARMACEUTICAL FORM:
Показання до застосування:
Extended release tablets
ATC class:
N03A Х14
Active substance:
LEVETIRACETAM
Склад:
1 ml of solution contains levetiracetam 100 mg;
excipients: liquid maltitol (Е 965), methyl parahydroxybenzoate (Е 218), propyl parahydroxybenzote (Е 216), glycerol, acesulfame potassium (Е 950), citric acid anhydrous, sodium citrate, sodium dihydrogen phosphate, dihydrate, sodium hydroxide, flavor “Lemon”, purified water.
Monotherapy (first-choice drug) in the treatment of: - partial seizures with or without secondary generalization in adults and adolescents from 16 years of age with newly diagnosed epilepsy. As adjunctive therapy in the treatment of: - partial seizures with or without secondary generalization in adults and children from 1 month of age with epilepsy; • myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy; • primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalized epilepsy.
